Use of RBM39 as a biomaker

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9556489
APP PUB NO 20150072892A1
SERIAL NO

14383395

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use (i) of a level of expression of a long RBM39 protein isoform, termed RBM39L, and (ii) of a level of expression of a short RBM39 protein isoform, termed RBM39C, as a marker for the efficacy of an active agent capable of preventing and/or treating HIV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITÉ DE MONTPELLIER34090 MONTPELLIER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campos, Noëlle Le Crés, FR 1 0
Garcel, Aude Le Cres, FR 16 120
Mahuteau-Betzer, Florence Saint-Remy-les-Chevreuse, FR 14 58
Najman, Romain L'Hay-les-Roses, FR 38 193
Scherrer, Didier Castelnau le Lez, FR 46 194
Tazi, Jamal Clapiers, FR 50 248
Venables, Julian Newcastle, GB 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 31, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00